Answers are grounded in this paper and cite their sources.
A lung cancer diagnostic kit (LCDK) with the advantages of low cost, easy operation and high sensitivity for the rapid diagnosis of lung cancer was developed. The proposed LCDK is able to noninvasively discriminate lung cancer using clinical salivary and urine samples in a short period of time.
No takes yet. Share an insight, caveat, or question.
Lü et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: